Cingulate Inc. (NASDAQ:CINGW) Short Interest Update

Cingulate Inc. (NASDAQ:CINGW) saw a large increase in short interest in May. As of May 29th, there was short interest totaling 10,882 shares, an increase of 186.7% from the May 14th total of 3,796 shares. Based on an average daily trading volume, of 57,882 shares, the days-to-cover ratio is currently 0.2 days.

Cingulate Stock Up 50.0%

Shares of CINGW traded up $0.01 during trading hours on Friday, reaching $0.03. 100 shares of the stock traded hands, compared to its average volume of 41,306. Cingulate has a 52-week low of $0.02 and a 52-week high of $0.18. The company’s 50-day moving average price is $0.02 and its two-hundred day moving average price is $0.05.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.